|1.||Lee, Kyung Bok: 1 article (12/2015)|
|2.||Park, Jung-Hwan: 1 article (12/2015)|
|3.||Park, Jong-Hwan: 1 article (12/2015)|
|4.||Oh, Sang-Muk: 1 article (12/2015)|
|5.||Choi, Hye-Jin: 1 article (12/2015)|
|6.||Wang, Jie: 1 article (04/2012)|
|7.||Wang, Yumei: 1 article (04/2012)|
|8.||Lu, Luo: 1 article (04/2012)|
|9.||Grant, Melissa M: 1 article (11/2010)|
|10.||Xu, Xingzhi: 1 article (01/2010)|
05/01/2009 - "SUMO proteins are thought to play roles in various cellular pathways, but no studies have as yet compared the expression of the different SUMO proteins in chemosensitive and drug-resistant cancer cells. "
05/01/2009 - "Differential expression patterns of SUMO proteins in HL-60 cancer cell lines support a role for sumoylation in the development of drug resistance."
03/08/2007 - "Our results therefore suggest that apoptin kills tumor cells independently of PML and sumoylation, however, the interaction of apoptin with PML and small ubiquitin-like modifier (SUMO) proteins might be relevant for CAV replication."
|2.||Neurodegenerative Diseases (Neurodegenerative Disease)
11/01/2010 - "The small ubiquitin-like modifier (SUMO) proteins have been implicated in the pathology of a number of diseases, including neurodegenerative diseases. "
04/14/2006 - "We have examined the covalent attachment of the small ubiquitin-like modifier (SUMO) proteins to tau and alpha-synuclein, two natively unfolded proteins that define several neurodegenerative diseases. "
|3.||Prostatic Neoplasms (Prostate Cancer)
|4.||Ataxia Telangiectasia (Louis Bar Syndrome)
01/01/2010 - "Krüppel-associated box (KRAB) domain-associated protein 1 [KAP1, also known as transcription intermediary factor-1beta (TIF1beta)] is a ubiquitous transcriptional co-repressor that is susceptible to phosphorylation at Ser(824) by ataxia-telangiectasia mutated (ATM) and to modification by small ubiquitin-like modifying (SUMO) proteins. "
|3.||Proteins (Proteins, Gene)